International
students

The IRCM is waiting for you!

An enriching
experience

Interested in pursuing graduate studies in biomedical research in Canada? The IRCM offers one of the most distinguished experiences available, both scientifically and on a personal level. Find out more about all the benefits that training at the IRCM can offer you.

The IRCM:
promoting excellence in
biomedical research

The IRCM is a state-of-the-art biomedical research institute and the research conducted there is world-renowned. Beyond the quality of its research, the Institute integrates an essential clinical component, cutting-edge technological platforms, and partnerships with Université de Montréal and McGill University. Training the next generation of researchers is one of the pillars of our mission and has been written in our DNA since the Institute’s founding in 1967.

A unique place to
live in America

Located right in the heart of Montreal and close to major universities, the IRCM moves to the rhythms of a bustling Latin Quarter with a European charm. Here, scientific endeavours are as rich as the city’s cultural life. Montreal is inclusive and open to the world, and its location makes it one of the most accessible major cities in America for pursuing studies. It is first and foremost a French-speaking city, but its multicultural nature makes English a shared language that is used in everyday communication.

Research
focus

thumbnail

Cardiometabolic
health research
center

thumbnail

Cancer
research
center

thumbnail

Genetic and
Neurological Diseases
Research Center

thumbnail

Center for Research
in Immunity, Inflammation
and Infectious Diseases

Our partners

Quebec’s
university system

The Quebec university system is aligned with the North American model which is composed of three levels of university study. The academic year includes three 15-week trimesters: the fall trimester (late August to mid-December), the winter trimester (January to April) and the summer trimester (May to August).

The first level of university study normally leads to a bachelor’s degree. It requires three to four years of study, and 90 to 120 credits are required to obtain a degree.

The first level of university study normally leads to a bachelor’s degree. It requires three to four years of study, and 90 to 120 credits are required to obtain a degree.

The second level of university study normally leads to a master’s degree in either a one- or two-year graduate course. The research-based master’s degree consists of 45 credits and includes a thesis requirement.

The second level of university study normally leads to a master’s degree in either a one- or two-year graduate course. The research-based master’s degree consists of 45 credits and includes a thesis requirement.

The third level of university study normally leads to a doctoral degree (PhD) after three to five years of study. The doctoral program consists of 90 credits and a thesis requirement which must be defended before a jury.

The third level of university study normally leads to a doctoral degree (PhD) after three to five years of study. The doctoral program consists of 90 credits and a thesis requirement which must be defended before a jury.

Immigrating
to Canada

Is your mind made up? Do you want to pursue studies at the IRCM? Check out these links for more useful information.

Québec International

Ministère de l’Immigration, de la Francisation 
et de l’Intégration du Québec

I choose Montréal

Helpful information is also available for international students at the international students office at Université de Montréal. .

Discoveries »

thumbnail

Discoveries

A genetic mutation that protects against disease

In a study published in the journal eLife, the team of Mathieu Ferron, Director of the Research Unit in Molecular Physiology at the IRCM, unveiled an optimized version of the hormone that could be the basis for innovative therapies. 

Read

thumbnail

Discoveries

Groundbreaking Advance in Lupus

The work of the team led by Dr. Hua Gu is published in the prestigious scientific journal "Immunity". This massive work is the first to identify a family of protein ubiquitin ligases (CBLs) as a common molecular trait causing Lupus in humans; a groundbreaking advance that could pave the way to future therapies in this field.

Read

Need some help?

Contact our Academic Affairs Office now.

Newsletter

Discoveries,
events and more

Subscribe

IRCM Foundation

Be part of the
solution

Support health research